Jia H P, Mills J N, Barahmand-Pour F, Nishimura D, Mallampali R K, Wang G, Wiles K, Tack B F, Bevins C L, McCray P B
Department of Pediatrics, University of Iowa College of Medicine, Iowa City, Iowa, USA.
Infect Immun. 1999 Sep;67(9):4827-33. doi: 10.1128/IAI.67.9.4827-4833.1999.
beta-Defensins are cationic peptides with broad-spectrum antimicrobial activity that may play a role in mucosal defenses of several organs. They have been isolated in several species, and in humans, two beta-defensins have been identified. Here, we report the identification of two genes encoding beta-defensin homologues in the rat. Partial cDNAs were found by searching the expressed-sequence-tag database, and primers were designed to generate full-length mRNA coding sequences. One gene was highly similar to the human beta-defensin-1 (HBD-1) gene and mouse beta-defensin-1 gene at both the nucleic acid and amino acid levels and was termed rat beta-defensin-1 (RBD-1). The other gene, named RBD-2, was homologous to the HBD-2 and bovine tracheal antimicrobial peptide (TAP) genes. The predicted prepropeptides were strongly cationic, were 69 and 63 residues in length for RBD-1 and RBD-2, respectively, and contained the six-cysteine motif characteristic of beta-defensins. The beta-defensin genes mapped closely on rat chromosome 16 and were closely linked to the alpha-defensins genes, suggesting that they are part of a gene cluster, similar to the organization reported for humans. Northern blot analysis showed that both RBD-1 and RBD-2 mRNA transcripts were approximately 0.5 kb in length; RBD-1 mRNA was abundantly transcribed in the rat kidney, while RBD-2 was prevalent in the lung. Reverse transcription-PCR indicated that RBD-1 and RBD-2 mRNAs were distributed in a variety of other tissues. In the lung, RBD-1 mRNA expression localized to the tracheal epithelium while RBD-2 was expressed in alveolar type II cells. In conclusion, we characterized two novel beta-defensin homologues in the rat. The rat may be a useful model to investigate the function and contribution of beta-defensins to host defense in the lung, kidney, and other tissues.
β-防御素是具有广谱抗菌活性的阳离子肽,可能在多个器官的黏膜防御中发挥作用。它们已在多个物种中被分离出来,在人类中,已鉴定出两种β-防御素。在此,我们报告在大鼠中鉴定出两个编码β-防御素同源物的基因。通过搜索表达序列标签数据库发现了部分cDNA,并设计引物以生成全长mRNA编码序列。一个基因在核酸和氨基酸水平上都与人类β-防御素-1(HBD-1)基因和小鼠β-防御素-1基因高度相似,被命名为大鼠β-防御素-1(RBD-1)。另一个基因名为RBD-2,与HBD-2和牛气管抗菌肽(TAP)基因同源。预测的前原肽具有强阳离子性,RBD-1和RBD-2的长度分别为69和63个残基,并包含β-防御素特有的六个半胱氨酸基序。β-防御素基因紧密定位在大鼠16号染色体上,并与α-防御素基因紧密连锁,表明它们是一个基因簇的一部分,类似于人类报道的基因组织。Northern印迹分析表明,RBD-1和RBD-2 mRNA转录本的长度均约为0.5 kb;RBD-1 mRNA在大鼠肾脏中大量转录,而RBD-2在肺中普遍存在。逆转录PCR表明,RBD-1和RBD-2 mRNA分布于多种其他组织中。在肺中,RBD-1 mRNA表达定位于气管上皮,而RBD-2在II型肺泡细胞中表达。总之,我们鉴定了大鼠中两种新的β-防御素同源物。大鼠可能是研究β-防御素在肺脏、肾脏和其他组织中对宿主防御的功能和作用的有用模型。